We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
White House adviser says pandemic nearly ‘on the run’ thanks to vaccination campaign
Hint that social-distancing restrictions could be lifted completely in the summer
The pandemic has seen a small but growing number decide to have children on their own
German group plans to invest proceeds in bid to become a leading force in cancer therapies
Property investors pile into life sciences sector as part of shift away from retail and offices
Computers are scanning millions of patients whose treatment has been derailed by the strain of the pandemic
European leaders say Washington’s call for waivers distracts from causes of supply squeeze
Beijing builds on Covid diplomacy as region endures crippling third wave
Move comes as wealthy Indians turn to black market in hunt for critical medical supplies
France and Germany back Brussels in pushing for more vaccine exports from rich countries
US president faced down pharma lobby and some in his administration
Adar Poonawalla and Serum Institute have come under withering criticism as Covid ravages India
IP dispute hinders access bottlenecks
Authorisation allows jab to be deployed by Covax in boost for Chinese pharma industry
Mutation has been linked to the alarming surge in infections in India
Declining infection rates mean potential risks from jab may outweigh dangers of disease
Prime minister accused of not planning adequately ahead of country’s second wave
Bar on citizens returning from India has been labelled racist, cruel and possibly illegal
EU is lukewarm on waiving patents for Covid-19 vaccines
Ethical questions on benefits of immunising the young will be crucial to how future doses are distributed
German leader warns loosening trade rules threatens production of Covid-19 therapies
Chief of vaccine maker says relaxing protections ‘will not help’ boost Covid jab supplies
Shares in Covid vaccine makers hit on worries waiver would harm profit and innovation
International Edition
